What is adalimumab 40mg injection?
adalimumab 40mg injection is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.
How adalimumab 40mg injection is given?
Adalimumab Injection is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get the maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better.
Common Side Effects of Injection:
Some of the common side effects of this Injection include headache, sinus inflammation, rash upper respiratory tract infection, and injection site reactions such as pain, redness, and swelling. Talk to your doctor if any of these side effects do not go away with time or get worse. Your doctor may help with ways to reduce or prevent these symptoms.
To make sure the medicine is safe for you, before taking it, let your doctor know if you have any problems with your heart, kidneys, or liver. You should also tell your problem to doctor about all the other medicines you are taking. It is important for pregnant women and breastfeeding women to ask the advice of their doctors before taking this medicine.
Precautions Before Using This Medicine:
- It is given by injection under the skin (via subcutaneous).
- Take it as per the dose and duration suggested by the doctor.
- Inform your doctor immediately if you notice a severe rash, hives, swelling of hands or face, and shortness of breath.
Do not stop taking the medication suddenly without talking to your doctor first…..For more details click here…
Brand Name: Mabura
Manufacturer: Hetero Healthcare
We export pharmaceutical products from India to different countries like the United Arab Emirates, the United States, Brazil, Saudi Arabia, etc. If you are looking for another product or brand click here…